Accounting management platform Sage announced it has acquired small business-focused expense management platform Fyle. The ...

Sage Therapeutics, Inc. (Nasdaq: SAGE), today reported business highlights and financial results for the second quarter ended June 30, 2025.

Supernus Pharmaceuticals has acquired Sage Therapeutics, strengthening its neuropsychiatry product portfolio.

--Today, Sage, the leader in accounting, financial, HR and payroll technology for small and mid-sized businesses, announced a major step forward in the development of connected accounting at its ...

New York City-based Wealthspire Advisors today announced that it has signed an agreement to purchase Sage Financial Advisors, Inc., a Reno, Nev.-based registered investment advisor with about $194 ...

The EFL has announced a new long-term partnership with Sage, a global leader in accounting, financial, HR, and payroll ...

SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system.

Wealthspire Advisors, a New York-based registered investment advisory firm managing $17 billion, has agreed to purchase Sage Financial Advisors, a Reno, Nevada-based RIA managing $194 million.